← Leaderboards
Pablo C Okhuysen
University Of Texas Hlth Sci Ctr Houston
$4,670,473
Attributed
$4,670,473
Total exposure
7
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $557.1K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,670,473 · 7
By mechanism
U19$2,215,793 · 1
R01$1,579,494 · 1
M01$875,186 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Charles Darkoh$5,306,635
- Anne-Marie Krachler$3,425,421
- Susan Marie Wall$12,075,661
- Andrew Paul Morris$1,539,235
- Wa Xian$4,191,802
Others in their field
Top investigators on “Cryptosporidium”
- Boris Striepen · University Of Pennsylvania$19,217,276
- Wesley C Van Voorhis · University Of Washington$13,225,240
- L David Sibley · Washington University$12,599,111
- Glenn D Kuehn · New Mexico State University Las Cruces$11,075,210
- Saul R Tzipori · Tufts University Boston$11,040,087
- Honorine D Ward · Tufts Medical Center$10,675,138
Research focus
CryptosporidiumDiarrheaVirulenceClinical ResearchCytokineImmune ResponseHuman SubjectEscherichia ColiCryptosporidiosisVolunteerPathogenesisPredispositionInfectionCryptosporidium ParvumMemberAreaExposure ToDeveloping CountriesAdultGenotypeFunctional DisorderPathogenBacterial CommunityCommunities
Grant awards (20)
Mucosal determinants of Cryptosporidium infection$557,142
U19 · FY2023 · AI · contact PI
Mucosal determinants of Cryptosporidium infection$557,143
U19 · FY2022 · AI · contact PI
Mucosal determinants of Cryptosporidium infection$440,083
U19 · FY2021 · AI · contact PI
Mucosal determinants of Cryptosporidium infection$294,923
U19 · FY2020 · AI · contact PI
Mucosal determinants of Cryptosporidium infection$366,502
U19 · FY2019 · AI · contact PI
Gene Polymorphisms Predisposing to Infectious Diarrhea$352,012
R01 · FY2007 · AI · contact PI
Gene Polymorphisms Predisposing to Infectious Diarrhea$362,526
R01 · FY2006 · AI · contact PI
Gene Polymorphisms Predisposing to Infectious Diarrhea$371,250
R01 · FY2005 · AI
INFECTIVITY OF CRYPTOSPORIDIUM PARVUM FOR ADULT HUMANS$85,902
M01 · FY2005 · RR
IL-2 (PROLEUKIN) IN HIV+ PATIENTS IN A RANDOMIZED INTERNATIONAL TRIAL (ESPRIT)$50,220
M01 · FY2005 · RR
COMPARISON OF THE CLINICAL CONSEQUENCES OF TWO ANTI-RETROVIRAL REGIMENS IN HIV$27,748
M01 · FY2005 · RR
UCRC SPECIAL CASE STUDY PROTOCOL$1,615
M01 · FY2005 · RR
Infectivity of Cryptosporidium parvum for adult humans$636,419
M01 · FY2004 · RR
Gene Polymorphisms Predisposing to Infectious Diarrhea$371,250
R01 · FY2004 · AI
IL-2 (Proleukin) in HIV+ patients in a randomized trial$45,259
M01 · FY2004 · RR
UCRC Special Case Study Protocol$12,909
M01 · FY2004 · RR
Gene Polymorphisms Predisposing to Infectious Diarrhea$122,456
R01 · FY2003 · AI
INFECTIVITY OF CRYPTOSPORIDIUM PARVUMFOR ADULT HUMANS$0
M01 · FY2002 · RR
INFECTIVITY OF CRYPTOSPORIDIUM PARVUMFOR ADULT HUMANS$0
M01 · FY2001 · RR
INFECTIVITY OF CRYPTOSPORIDIUM PARVUMFOR ADULT HUMANS$15,114
M01 · FY2000 · RR